Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients

Molecular Biology Reports

Volumn 37, Issue 1, 2010, Pages 325-332

  Kiwerska, Katarzyna ^a   Rydzanicz, Małgorzata ^a   Kram, Andrzej ^b   Pastok, Martyna ^a   Antkowiak, Agata ^a   Domagała, Wenancjusz ^b   Szyfter, Krzysztof ^a,c  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ankyrin repeats; CDKN2A gene mutations; Cell cycle; Larynx cancer

Indexed keywords

ANKYRIN; ASPARTIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTIDINE; TRYPTOPHAN; TYROSINE;

ARTICLE; CARCINOGENESIS; CODON; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; LARYNX CANCER; MUTATIONAL ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE;

BASE SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA MUTATIONAL ANALYSIS; EXONS; HUMANS; INTRONS; LARYNGEAL NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; OPEN READING FRAMES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 77949265538     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9731-z     Document Type: Article

References (55)

1. M Serrano GJ Hannon D Beach 1993 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 704 707 10.1038/366704a0 1:CAS:528:DyaK2cXhsFOgu7Y%3D 8259215 (Pubitemid 24036021)
2. WM Lydiatt BJ Davidson SP Schantz S Caruana RS Chaganti 1998 9p21 deletion correlates with recurrence in head and neck cancer Head Neck 20 113 118 10.1002/(SICI)1097-0347(199803)20:2<113::AID-HED3>3.0.CO;2-5 1:STN:280:DyaK1c7ktlCksA%3D%3D 9484941 (Pubitemid 28106222)
3. DG Danahey EJ Tobin DE Schuller CM Bier-Laning CM Weghorst JC Lang 1999 p16 mutation frequency and clinical correlation in head and neck cancer Acta Otolaryngol 119 285 288 10.1080/00016489950181837 1:CAS:528:DC%2BD3MXitlCnsrg%3D 10320093 (Pubitemid 29177085)
4. D Akanuma N Uzawa MA Yoshida A Negishi T Amagasa T Ikeuchi 1999 Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines Oral Oncol 35 476 483 10.1016/S1368-8375(99)00020-2 1:CAS:528:DyaK1MXlsFCht7s%3D 10694947 (Pubitemid 29386783)
5. M Giefing JI Martin-Subero K Kiwerska M Jarmuz R Grenman R Siebert K Szyfter 2008 Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines Cancer Genet Cytogenet 184 38 43 10.1016/j.cancergencyto. 2008.03.004 1:CAS:528:DC%2BD1cXnt1Omtb8%3D 18558287 (Pubitemid 351818227)
6. JW Rocco D Sidransky 2001 p16(MTS-1/CDKN2/INK4a) in cancer progression Exp Cell Res 264 42 55 10.1006/excr.2000.5149 1:CAS:528:DC%2BD3MXhsFOhu78%3D 11237522 (Pubitemid 32989080)
7. A Kamb NA Gruis J Weaver-Feldhaus Q Liu K Harshman SV Tavtigian E Stockert RS Day 3rd BE Johnson MH Skolnick 1994 A cell cycle regulator potentially involved in genesis of many tumor types Science 264 436 440 10.1126/science.8153634 1:CAS:528:DyaK2cXktVKhtb0%3D 8153634
8. P Cairns L Mao A Merlo DJ Lee D Schwab Y Eby K Tokino P van der Riet JE Blaugrund D Sidransky 1994 Rates of p16 (MTS1) mutations in primary tumors with 9p loss Science 265 415 417 10.1126/science.8023167 1:CAS:528:DyaK2cXlt1KltrY%3D 8023167
9. A Merlo JG Herman L Mao DJ Lee E Gabrielson PC Burger SB Baylin D Sidransky 1995 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nat Med 1 686 692 10.1038/nm0795-686 1:CAS:528:DyaK2MXms1Kgtr4%3D 7585152
10. JG Herman A Merlo L Mao RG Lapidus JP Issa NE Davidson D Sidransky SB Baylin 1995 Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers Cancer Res 55 4525 4530 1:CAS:528:DyaK2MXoslWmsrk%3D 7553621
11. GM Maelandsmo JM Berner VA Flørenes A Forus E Hovig O Fodstad O Myklebost 1995 Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1 Br J Cancer 72 393 398 1:CAS:528:DyaK2MXnsFSitbc%3D 7640224
12. MR Rusin A Okamoto M Chorazy K Czyzewski J Harasim EA Spillare K Hagiwara SP Hussain Y Xiong DJ Demetrick CC Harris 1996 Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers Int J Cancer 65 734 739 10.1002/(SICI)1097-0215(19960315)65:6<734::AID-IJC4>3. 0.CO;2-# 1:CAS:528:DyaK28XisV2hsL0%3D 8631583 (Pubitemid 26127750)
13. AL Reed J Califano P Cairns WH Westra RM Jones W Koch S Ahrendt Y Eby D Sewell H Nawroz J Bartek D Sidransky 1996 High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma Cancer Res 56 3630 3633 1:CAS:528:DyaK28XltVKlu7g%3D 8705996
14. P Jares PL Fernández A Nadal M Cazorla L Hernández M Pinyol S Hernández J Traserra A Cardesa E Campo 1997 p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx Oncogene 15 1445 1453 10.1038/sj.onc. 1201309 1:CAS:528:DyaK2sXmsFCit78%3D 9333020
15. S Shintani Y Nakahara M Mihara Y Ueyama T Matsumura 2001 Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas Oral Oncol 37 498 504 10.1016/S1368-8375(00)00142-1 1:CAS:528:DC%2BD3MXkvVektrk%3D 11435176 (Pubitemid 32588775)
16. A Tripathi Bhar S Banerjee N Chunder A Roy A Sengupta B Roy S Roychowdhury CK Panda 2003 Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients J Cancer Res Clin Oncol 129 642 650 10.1007/s00432-003-0485-z 14586645 (Pubitemid 37452630)
17. E Grafström S Egyházi U Ringborg J Hansson A Platz 2005 Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival Clin Cancer Res 11 2991 2997 10.1158/1078-0432.CCR-04-1731 15837753 (Pubitemid 40525204)
18. XQ Guo SJ Wang LW Zhang XL Wang JH Zhang W Guo 2007 DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area J Exp Clin Cancer Res 26 587 594 1:CAS:528:DC%2BD1cXitFSiu78%3D 18365557
19. MV Brock CM Hooker E Ota-Machida Y Han M Guo S Ames S Glöckner S Piantadosi E Gabrielson G Pridham K Pelosky SA Belinsky SC Yang SB Baylin JG Herman 2008 DNA methylation markers and early recurrence in stage I lung cancer N Engl J Med 358 1118 1128 10.1056/NEJMoa0706550 1:CAS:528:DC%2BD1cXjt1aiurc%3D 18337602
20. MR Abbaszadegan O Moaven HR Sima K Ghafarzadegan A A'rabi MN Forghani HR Raziee A Mashhadinejad M Jafarzadeh E Esmaili-Shandiz E Dadkhah 2008 p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer World J Gastroenterol 14 2055 2060 10.3748/wjg.14.2055 1:CAS:528:DC%2BD1cXnvFShurw%3D 18395906 (Pubitemid 351795826)
21. SY Zhang AJ Klein-Szanto ER Sauter M Shafarenko S Mitsunaga T Nobori DA Carson JA Ridge TL Goodrow 1994 Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck Cancer Res 54 5050 5053 1:CAS:528:DyaK2cXmt1emu7k%3D 7923115
22. P Cairns TJ Polascik Y Eby K Tokino J Califano A Merlo L Mao J Herath R Jenkins W Westra 1995 Frequency of homozygous deletion at p16/CDKN2 in primary human tumours Nat Genet 11 210 212 10.1038/ng1095-210 1:CAS:528: DyaK2MXosF2rt70%3D 7550353
23. AF Olshan MC Weissler H Pei K Conway S Anderson DB Fried WG Yarbrough 1997 Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV Oncogene 14 811 818 10.1038/sj.onc.1200892 1:CAS:528:DyaK2sXhs1Gksb8%3D 9047388
24. U Riese R Dahse W Fiedler C Theuer S Koscielny G Ernst E Beleites U Claussen F von Eggeling 1999 Tumor suppressor gene p16 (CDKN2A) mutation status and promotor inactivation in head and neck cancer Int J Mol Med 4 61 65 1:CAS:528:DyaK1MXktFCrt7s%3D 10373639
25. EC Miracca LP Kowalski MA Nagai 1999 High prevalence of p16 genetic alterations in head and neck tumours Br J Cancer 81 677 683 10.1038/sj.bjc. 6690747 1:CAS:528:DyaK1MXntVSqurs%3D 10574255 (Pubitemid 29458865)
26. M Sanchez-Cespedes M Esteller L Wu H Nawroz-Danish GH Yoo WM Koch J Jen JG Herman D Sidransky 2000 Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res 60 892 895 1:CAS:528: DC%2BD3cXhs1Shsrw%3D 10706101
27. MJ Poi T Yen J Li H Song JC Lang DE Schuller DK Pearl BC Casto MD Tsai CM Weghorst 2001 Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck Mol Carcinog 30 26 36 10.1002/1098-2744(200101)30:1<26::AID-MC1010>3.0.CO;2-E 1:CAS:528:DC%2BD3MXhtFertbg%3D 11255261 (Pubitemid 32127347)
28. SL Rosas W Koch MG da Costa Carvalho L Wu J Califano W Westra J Jen D Sidransky 2001 Promoter hypermethylation patterns of p16, O6-methylguanine-DNA- methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients Cancer Res 61 939 942 1:CAS:528: DC%2BD3MXhsFSrurg%3D 11221887
29. M Hasegawa HH Nelson E Peters E Ringstrom M Posner KT Kelsey 2002 Patterns of gene promoter methylation in squamous cell cancer of the head and neck Oncogene 21 4231 4236 10.1038/sj.onc.1205528 1:CAS:528:DC%2BD38XkslKmtL0%3D 12082610 (Pubitemid 34753829)
30. A Weber U Bellmann F Bootz C Wittekind A Tannapfel 2002 INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck Virchows Arch 441 133 142 10.1007/s00428-002-0637-6 1:CAS:528:DC%2BD38Xmt1Wju7Y%3D 12189502 (Pubitemid 34983979)
31. K Kato A Hara T Kuno H Mori T Yamashita M Toida T Shibata 2006 Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa J Cancer Res Clin Oncol 132 735 743 10.1007/s00432-006-0122-8 1:CAS:528:DC%2BD28XptVajs7g%3D 16791592 (Pubitemid 44337934)
32. S Koscielny R Dahse G Ernst F von Eggeling 2007 The prognostic relevance of p16 inactivation in head and neck cancer ORL J Otorhinolaryngol Relat Spec 69 30 36 17085950
33. K Szukała A Sowińska M Wierzbicka W Biczysko W Szyfter K Szyfter 2006 Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy? Mutat Res 600 67 76 16814812
34. P van der Riet H Nawroz RH Hruban R Corio K Tokino W Koch D Sidransky 1994 Frequent loss of chromosome 9p21-22 early in head and neck cancer progression Cancer Res 54 1156 1158 8118798
35. MV González MF Pello C López-Larrea C Suárez MJ Menéndez E Coto 1995 Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck Clin Cancer Res 1 1043 1049 9816078
36. P Waber S Dlugosz QC Cheng J Truelson PD Nisen 1997 Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a Oncogene 15 1699 1704 10.1038/sj.onc.1201336 1:CAS:528: DyaK2sXmslClu7s%3D 9349503
37. WG Yarbrough RA Buckmire M Bessho ET Liu 1999 Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors J Natl Cancer Inst 91 1569 1574 10.1093/jnci/91.18.1569 1:CAS:528:DyaK1MXmsVCrt7k%3D 10491434
38. M Ruas S Brookes NQ McDonald G Peters 1999 Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information Oncogene 18 5423 5434 10.1038/sj.onc.1202918 1:CAS:528: DyaK1MXms1OhsLs%3D 10498896 (Pubitemid 29469230)
39. K Ranade CJ Hussussian RS Sikorski HE Varmus AM Goldstein MA Tucker M Serrano GJ Hannon D Beach NC Dracopoli 1995 Mutations associated with familial melanoma impair p16INK4 function Nat Genet 10 114 116 10.1038/ng0595-114 1:CAS:528:DyaK2MXlsVymt7w%3D 7647780
40. M Serrano H Lee L Chin C Cordon-Cardo D Beach RA DePinho 1996 Role of the INK4a locus in tumor suppression and cell mortality Cell 85 27 37 10.1016/S0092-8674(00)81079-X 1:CAS:528:DyaK28Xit1aksb8%3D 8620534 (Pubitemid 26116804)
41. CJ Hussussian JP Struewing AM Goldstein PA Higgins DS Ally MD Sheahan WH Clark Jr MA Tucker NC Dracopoli 1994 Germline p16 mutations in familial melanoma Nat Genet 8 15 21 10.1038/ng0994-15 1:CAS:528:DyaK2cXmtVantrg%3D 7987387 (Pubitemid 24274055)
42. B Zhang Z Peng 2000 A minimum folding unit in the ankyrin repeat protein p16(INK4) J Mol Biol 299 1121 1132 10.1006/jmbi.2000.3803 1:CAS:528: DC%2BD3cXjvVSrsrs%3D 10843863 (Pubitemid 30700987)
43. M Harland R Meloni N Gruis E Pinney S Brookes NK Spurr AM Frischauf V Bataille G Peters J Cuzick P Selby DT Bishop JN Bishop 1997 Germline mutations of the CDKN2 gene in UK melanoma families Hum Mol Genet 6 2061 2067 10.1093/hmg/6.12.2061 1:CAS:528:DyaK2sXntFWrt7o%3D 9328469 (Pubitemid 27477947)
44. S Karsai U Abel M Roesch-Ely A Affolter C Hofele S Joos PK Plinkert FX Bosch 2007 Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis J Pathol 211 314 322 10.1002/path.2100 1:CAS:528:DC%2BD2sXisFyksLo%3D 17152048 (Pubitemid 46172707)
45. C Caldas SA Hahn LT da Costa MS Redston M Schutte AB Seymour CL Weinstein RH Hruban CJ Yeo SE Kern 1994 Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 27 32 10.1038/ng0994-27 1:CAS:528:DyaK2cXmtVajsL0%3D 7726912 (Pubitemid 24274057)
46. K Ueki Y Ono JW Henson JT Efird A von Deimling DN Louis 1996 CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Res 56 150 153 1:CAS:528:DyaK28Xit1ChtQ%3D%3D 8548755
47. PM Pollock F Yu L Qiu PG Parsons NK Hayward 1995 Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines Oncogene 11 663 668 1:CAS:528:DyaK2MXnslCjtLg%3D 7651729
48. M Castellano PM Pollock MK Walters LE Sparrow LM Down BG Gabrielli PG Parsons NK Hayward 1997 CDKN2A/p16 is inactivated in most melanoma cell lines Cancer Res 57 4868 4875 1:CAS:528:DyaK2sXnt12nsro%3D 9354451
49. J Smeds P Berggren X Ma Z Xu K Hemminki R Kumar 2002 Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF)) and p53 genes are major targets for inactivation Carcinogenesis 23 645 655 10.1093/carcin/23.4.645 1:CAS:528:DC%2BD38XjvVGrurg%3D 11960918
50. I Orlow H LaRue I Osman L Lacombe L Moore F Rabbani F Meyer Y Fradet C Cordon-Cardo 1999 Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence Am J Pathol 155 105 113 1:CAS:528:DyaK1MXkslegtL0%3D 10393843
51. T Ueki AW Hsing YT Gao BS Wang MC Shen J Cheng J Deng JF Fraumeni Jr A Rashid 2004 Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China Clin Cancer Res 10 1717 1725 10.1158/1078-0432.CCR-1137-3 1:CAS:528:DC%2BD2cXhvFCltrg%3D 15014024 (Pubitemid 38435563)
52. IJ Byeon J Li K Ericson TL Selby A Tevelev HJ Kim P O'Maille MD Tsai 1998 Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4 Mol Cell 1 421 431 10.1016/S1097-2765(00)80042-8 1:CAS:528:DyaK1cXhtlyhurw%3D 9660926
53. T Debniak RJ Scott T Huzarski T Byrski A Rozmiarek B Debniak E Załuga R Maleszka J Kładny B Górski C Cybulski J Gronwald G Kurzawski J Lubinski 2005 CDKN2A common variants and their association with melanoma risk: a population-based study Cancer Res 65 835 839 1:CAS:528:DC%2BD2MXhtVWnt7g%3D 15705881
54. A Kamb D Shattuck-Eidens R Eeles Q Liu NA Gruis W Ding C Hussey T Tran Y Miki J Weaver-Feldhaus 1994 Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus Nat Genet 8 23 26 10.1038/ng0994-22 1:STN:280:DyaK2M%2FnvV2itQ%3D%3D 7987388 (Pubitemid 24274056)
55. C Jin Y Jin J Wennerberg J Akervall M Dictor F Mertens 2002 Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck Cancer Genet Cytogenet 132 85 96 10.1016/S0165-4608(01)00535-0 1:CAS:528:DC%2BD38Xht1ajtrw%3D 11850067 (Pubitemid 34170864)